Adrenomedullin gene transfer induces neointimal apoptosis and inhibits neointimal hyperplasia in injured rat artery

Journal of Gene Medicine

Volumn 8, Issue 4, 2006, Pages 452-458

  Rauma Pinola, Tanja ^a   Pääkkö, Paavo ^a   Ilves, Mika ^a   Serpi, Raisa ^a   Romppanen, Hannu ^a   Vuolteenaho, Olli ^a   Ruskoaho, Heikki ^a   Hautala, Timo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apoptosis; Myofibroblast; Neointima; Restenosis

Indexed keywords

ADENOVIRUS VECTOR; ADRENOMEDULLIN; ALPHA SMOOTH MUSCLE ACTIN; BETA GALACTOSIDASE; DESMIN; MULTIDRUG RESISTANCE PROTEIN 1; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY INJURY; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; GENE OVEREXPRESSION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RAT STRAIN; STEM CELL MOBILIZATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ACTINS; ADENOVIRIDAE; ADRENOMEDULLIN; ANIMALS; APOPTOSIS; ARTERIES; CAROTID ARTERIES; DESMIN; GENE EXPRESSION; HYPERPLASIA; MALE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TRANSDUCTION, GENETIC; TRANSGENES; TUNICA INTIMA;

ADENOVIRIDAE; ANIMALIA;

EID: 33646236911     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.865     Document Type: Article

References (50)

1. Siow RC, Mallawaarachchi CM, Weissberg PL. Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries. Cardiovasc Res 2003; 59: 212-221.
2. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-215.
3. Li S, Fan YS, Chow LH, et al. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 2001; 89: 517-525.
4. Li G, Chen SJ, Oparil S, et al. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000; 101: 1362-1365.
5. Han CI, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001; 38:113-119.
6. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
7. Bayes-Genis A, Campbell JH, Carlson PJ, et al. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis 2002; 163: 89-98.
8. Zohlnhofer D, Klein CA, Richter T, et al. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation. Circulation 2001; 103: 1396-1402.
9. Zohlnhofer D, Richter T, Neumann F, et al. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 2001; 7: 1059-1069.
10. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
11. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-1166.
12. Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 1994; 203: 719-726.
13. Horio T, Nishikimi T, Yoshihara F, et al. Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1beta and tumor necrosis factor-alpha. Endocrinology 1998; 139: 4576-4580.
14. Nishimori T, Tsujino M, Sato K, et al. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J Mol Cell Cardiol 1997; 29: 2125-2130.
15. Kubo A, Minamino N, Isumi Y, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 1998; 273: 16730-16738.
16. Nakayama M, Takahashi K, Murakami O, et al. Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci (Lond) 1999; 97: 247-251.
17. Kitamura K, Ichiki Y, Tanaka M, et al. Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994; 341: 288-290.
18. Sato K, Hirata Y, Imai T, et al. Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 1995; 57: 189-194.
19. Meeran K, O'Shea D, Upton PD, et al. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J Clin Endocrinol Metab 1997; 82: 95-100.
20. Kano H, Kohno M, Yasunari K, et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996; 14: 209-213.
21. Horio T, Kohno M, Kano H, et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 1995; 77: 660-664.
22. Kohno M, Yokokawa K, Kano H, et al. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells. Hypertension 1997; 29: 1309-1313.
23. Kato H, Shichiri M, Marumo F, et al. Adrenomedullin as an autocrine/ paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997; 138: 2615-2620.
24. Sata M, Kakoki M, Nagata D, et al. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 2000; 36: 83-88.
25. Kato J, Tsuruda T, Kita T, et al. Adrenomedullin. A Protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005; Sep 1; [Epub ahead of print].
26. Agata J, Zhang JJ, Chao J, et al. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regul Pept 2003; 112: 115-120.
27. Imai Y, Shindo T, Maemura K, et al. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler Thromb Vasc Biol 2002; 22: 1310-1315.
28. Shimizu K, Tanaka H, Sunamori M, et al. Adrenomedullin receptor antagonism by calcitonin gene-related peptide(8-37) inhibits carotid artery neointimal hyperplasia after balloon injury. Circ Res 1999; 85: 1199-1205.
29. Fishman JA, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 1975; 32: 339-351.
30. Jones N, Shenk T. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci U S A 1979; 76: 3665-3669.
31. Rowe DT, Graham FL, Branton PE. Intracellular localization of adenovirus type 5 tumor antigens in productively infected cells. Virology 1983; 129: 456-468.
32. Romppanen H, Marttila M, Magga J, et al. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 1997; 138: 2636-2639.
33. Davidson BL, Doran SE, Shewach DS, et al. Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp Neurol 1994; 125: 258-267.
34. Majalahti-Palviainen T, Hirvinen M, Tervonen V, et al. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 2000; 141: 731-740.
35. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002; 415: 240-243.
36. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
37. Liu N, Chen G, Wang X, et al. Effects of certain vasoactive peptides on pathogenesis of vascular restenosis. Chin Med Sci J 2003; 18: 1-8.
38. Parameswaran N, Nambi P, Brooks DP, et al. Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin. Eur J Pharmacol 1999; 372: 85-95.
39. Chini EN, Chini CC, Bolliger C, et al. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int 1997; 52: 917-925.
40. Nishimatsu H, Suzuki E, Nagata D, et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 2001; 89: 63-70.
41. Kim W, Moon SO, Sung MJ, et al. Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 2003; 17: 1937-1939.
42. Chiche JD, Schlutsmeyer SM, Bloch DB, et al. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem 1998; 273: 34263-34271.
43. Casscells W, Engler D, Willerson JT. Mechanisms of restenosis. Tex Heart Inst J 1994; 21: 68-77.
44. Ylä-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000; 355: 213-222.
45. Jiang X, Gurel O, Mendiaz EA, et al. Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J 2000; 19: 3192-3203.
46. Bunting KD, Zhou S, Lu T, et al. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 2000; 96: 902-909.
47. Nadal-Ginard B, Kajstura J, Leri A, et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003; 92: 139-150.
48. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363.
49. Szokodi I, Kinnunen P, Tavi P, et al. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998; 97: 1062-1070.
50. Martinez A, Zudaire E, Portal-Nunez S, et al. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res 2004; 64: 6489-6494.